ShowcasesPricing
  1. US-listed companies
  2. Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.CYCC

Market cap
$27.56M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data